Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Kerr

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|November 27, 2007
Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparisonLiza L Ilag, Lisa Kerr, James K Malone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2014
Alopecia and nail changes associated with voriconazole therapyAnurag N Malani, Lisa Kerr, Janet Obear, et al.
Teaching and Learning in Medicine|March 28, 2013
The value of a writing center at a medical universityJennie Ariail, Suzanne Thomas, Tom Smith, et al.
Journal of Infection and Public Health|May 13, 2025
Particle filtration efficiency of respirators during the COVID-19 pandemicJackson Williams, Lucan Baillie, Wayne Clancy, et al.
The Journal of Investigative Dermatology|May 12, 2018
Ixekizumab Pharmacokinetics, Anti-Drug Antibodies, and Efficacy through 60 Weeks of Treatment of Moderate to Severe Plaque PsoriasisKristian Reich, Kimberley Jackson, Susan Ball, et al.
Clinical Pharmacokinetics|February 10, 2021
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with MigraineMax Tsai, Emel Serap Monkul Nery, Lisa Kerr, et al.
Journal of Virological Methods|February 20, 2026
Detection of Cell Impurities and NF-κB activation Using SEAP Reporter Cell Lines in VaccinesSarah K Mercier, Georgia Gilmayer, Jackson Williams, et al.
The Journal of Dermatological Treatment|October 21, 2016
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)Kristian Reich, Craig Leonardi, Mark Lebwohl, et al.
Current Medical Research and Opinion|February 10, 2006
Functionality and acceptability of a new electronic insulin injection pen with a memory featureWillem J R R Venekamp, Lisa Kerr, Sherie A Dowsett, et al.
Rheumatology (Oxford, England)|July 28, 2018
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2Mark C Genovese, Benard Combe, Joel M Kremer, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|November 27, 2007
Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparisonLiza L Ilag, Lisa Kerr, James K Malone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2014
Alopecia and nail changes associated with voriconazole therapyAnurag N Malani, Lisa Kerr, Janet Obear, et al.
Teaching and Learning in Medicine|March 28, 2013
The value of a writing center at a medical universityJennie Ariail, Suzanne Thomas, Tom Smith, et al.
Journal of Infection and Public Health|May 13, 2025
Particle filtration efficiency of respirators during the COVID-19 pandemicJackson Williams, Lucan Baillie, Wayne Clancy, et al.
The Journal of Investigative Dermatology|May 12, 2018
Ixekizumab Pharmacokinetics, Anti-Drug Antibodies, and Efficacy through 60 Weeks of Treatment of Moderate to Severe Plaque PsoriasisKristian Reich, Kimberley Jackson, Susan Ball, et al.
Clinical Pharmacokinetics|February 10, 2021
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with MigraineMax Tsai, Emel Serap Monkul Nery, Lisa Kerr, et al.
Journal of Virological Methods|February 20, 2026
Detection of Cell Impurities and NF-κB activation Using SEAP Reporter Cell Lines in VaccinesSarah K Mercier, Georgia Gilmayer, Jackson Williams, et al.
The Journal of Dermatological Treatment|October 21, 2016
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)Kristian Reich, Craig Leonardi, Mark Lebwohl, et al.
Current Medical Research and Opinion|February 10, 2006
Functionality and acceptability of a new electronic insulin injection pen with a memory featureWillem J R R Venekamp, Lisa Kerr, Sherie A Dowsett, et al.
Rheumatology (Oxford, England)|July 28, 2018
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2Mark C Genovese, Benard Combe, Joel M Kremer, et al.
Pageof 3